The Truth About GLP-1 Weight Loss Drugs - What Every Adult Over 50 Needs to Know.

Millions of people are taking Ozempic®, Wegovy®, Mounjaro®, Zepbound®, and other GLP-1 medications—but what are they, and how do they actually work? In this episode of my GLP-1 series, I'll explain: What GLP-1 medications are How they affect your brain, stomach, and blood sugar Why they're helping so many people lose weight The differences between weight loss and fat loss What every adult over 50 should understand before starting one of these medications I'm not here to tell you these medications are good or bad. I'm here to help you understand them so you can make informed decisions and protect your long-term health. As a personal trainer with more than 40 years of experience, I've seen what works—and what people often overlook. One of the biggest mistakes is focusing only on the number on the scale while ignoring muscle, strength, and long-term function. That's why I teach my **3-W Approach to Fitness**: *Weight Training* – Build and preserve the muscle that supports metabolism, mobility, and independence. *Walking* – Improve cardiovascular health, endurance, and overall wellness. *Watching Your Diet* – Make smart nutrition choices that support lasting results. If you're considering a GLP-1 medication—or you're already taking one—this series is for you. Subscribe so you don't miss the upcoming episodes, where we'll compare Ozempic, Wegovy, Mounjaro, Zepbound, Retatrutide, and other medications, discuss potential benefits and risks, and explain why strength training may be the most important part of your success. *Disclaimer:* This video is for educational purposes only and is not medical advice. Always consult your physician or other qualified healthcare professional before starting, stopping, or changing any medication or exercise program. You could also add a few searchable hashtags at the end: *#GLP1 #Ozempic #Wegovy #Mounjaro #Zepbound #Retatrutide #WeightLoss #StrengthTraining #Over50Fitness #HealthyAging #FitnessAndMore #SteveMcKinney*